104.55
price down icon0.46%   -0.12
 
loading
Precedente Chiudi:
$104.67
Aprire:
$104.03
Volume 24 ore:
24,434
Relative Volume:
0.03
Capitalizzazione di mercato:
$25.05B
Reddito:
$3.13B
Utile/perdita netta:
$-381.72M
Rapporto P/E:
-65.27
EPS:
-1.6017
Flusso di cassa netto:
$-2.15B
1 W Prestazione:
-1.39%
1M Prestazione:
+5.64%
6M Prestazione:
+0.03%
1 anno Prestazione:
-7.88%
Intervallo 1D:
Value
$103.34
$104.29
Intervallo di 1 settimana:
Value
$101.90
$107.32
Portata 52W:
Value
$81.20
$129.27

Biontech Se Adr Stock (BNTX) Company Profile

Name
Nome
Biontech Se Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
6,772
Name
Cinguettio
@BioNTech_Group
Name
Prossima data di guadagno
2025-03-10
Name
Ultimi documenti SEC
Name
BNTX's Discussions on Twitter

Confronta BNTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BNTX
Biontech Se Adr
104.20 25.17B 3.13B -381.72M -2.15B -1.6017
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.11 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.39 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.36 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
817.00 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
192.96 41.29B 398.11M -1.03B -868.57M -5.7032

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-05 Reiterato H.C. Wainwright Buy
2025-05-29 Iniziato Goldman Neutral
2025-03-13 Iniziato Citigroup Buy
2025-01-10 Iniziato Truist Buy
2024-12-11 Iniziato Wells Fargo Overweight
2024-12-02 Reiterato BMO Capital Markets Outperform
2024-11-19 Iniziato Berenberg Buy
2024-11-19 Aggiornamento Evercore ISI In-line → Outperform
2024-11-08 Aggiornamento Goldman Neutral → Buy
2024-09-24 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-09-17 Aggiornamento Jefferies Hold → Buy
2024-09-16 Aggiornamento JP Morgan Underweight → Neutral
2024-08-07 Aggiornamento Deutsche Bank Hold → Buy
2024-08-02 Aggiornamento HSBC Securities Hold → Buy
2024-05-14 Iniziato Evercore ISI In-line
2024-02-23 Iniziato BMO Capital Markets Outperform
2024-01-05 Iniziato Oppenheimer Perform
2023-12-01 Downgrade JP Morgan Neutral → Underweight
2023-10-16 Downgrade HSBC Securities Buy → Hold
2023-07-14 Iniziato HSBC Securities Buy
2023-05-17 Aggiornamento Redburn Neutral → Buy
2022-12-15 Aggiornamento BofA Securities Neutral → Buy
2022-08-17 Iniziato Cowen Market Perform
2022-07-13 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-07-06 Ripresa Canaccord Genuity Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2021-12-16 Iniziato Morgan Stanley Equal-Weight
2021-11-10 Aggiornamento H.C. Wainwright Neutral → Buy
2021-10-22 Iniziato Deutsche Bank Hold
2021-10-07 Iniziato Jefferies Hold
2021-08-11 Aggiornamento Bryan Garnier Neutral → Buy
2021-07-19 Ripresa Wolfe Research Outperform
2021-06-16 Downgrade Redburn Neutral → Sell
2021-05-18 Iniziato Goldman Neutral
2021-05-11 Downgrade Bryan Garnier Buy → Neutral
2020-12-01 Downgrade BofA Securities Buy → Neutral
2020-08-03 Ripresa Berenberg Buy
2020-07-21 Aggiornamento BofA Securities Neutral → Buy
2020-06-30 Downgrade H.C. Wainwright Buy → Neutral
2020-05-19 Aggiornamento H.C. Wainwright Neutral → Buy
2020-04-28 Downgrade BofA/Merrill Buy → Neutral
2020-03-18 Downgrade JP Morgan Overweight → Neutral
2020-03-09 Iniziato H.C. Wainwright Neutral
2020-01-24 Downgrade SVB Leerink Outperform → Mkt Perform
2020-01-22 Downgrade UBS Buy → Neutral
2019-11-05 Iniziato Wolfe Research Outperform
2019-11-04 Iniziato Berenberg Buy
2019-11-04 Iniziato BofA/Merrill Buy
2019-11-04 Iniziato Canaccord Genuity Buy
2019-11-04 Iniziato JP Morgan Overweight
2019-11-04 Iniziato SVB Leerink Outperform
2019-11-04 Iniziato UBS Buy
Mostra tutto

Biontech Se Adr Borsa (BNTX) Ultime notizie

pulisher
03:11 AM

BioNTech’s Promising Clinical Study: A New Hope for Advanced Solid Tumors? - TipRanks

03:11 AM
pulisher
02:11 AM

BioNTech SE’s Promising Phase 3 Study on NSCLC Treatment: A Potential Game-Changer - TipRanks

02:11 AM
pulisher
Oct 29, 2025

BioNTech’s Latest Clinical Study: A New Hope for Advanced Solid Tumors? - TipRanks

Oct 29, 2025
pulisher
Oct 28, 2025

ETFs Investing in BioNTech SE Sponsored ADR Stocks - TradingView

Oct 28, 2025
pulisher
Oct 27, 2025

Genmab and BioNTech’s Promising Study on Metastatic Colorectal Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Bristol-Myers Squibb and BioNTech’s New Study: A Potential Game-Changer in Cancer Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Bristol-Myers Squibb and BioNTech Launch New Colorectal Cancer Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Promising Study on BNT113 and Pembrolizumab for Head and Neck Cancer - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game Changer - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Promising PDAC Study: Market Implications and Progress - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Promising Phase 1/2a Trial: A New Hope for Advanced Solid Tumors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s BNT116 Study: A New Hope for Advanced Lung Cancer? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Promising Phase II Study on MIUC: A Potential Game-Changer? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s BNT326 Study: A New Hope for Advanced Tumor Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Bristol-Myers Squibb and BioNTech SE Launch New Study on Pumitamig for Triple-Negative Breast Cancer - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Pfizer and BioNTech’s New Study on Variant-Adapted COVID-19 Vaccine for Children: What Investors Need to Know - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech SE’s Promising Phase II Study on Advanced Solid Tumors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech SE’s New Study on PM8002: A Potential Game-Changer in Colorectal Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Pfizer and BioNTech’s New Vaccine Study: A Potential Game-Changer for COVID-19 Prevention - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s Latest Clinical Trial: A Potential Game-Changer in Breast Cancer Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

BioNTech’s BNT317 Study: A New Hope for Advanced Solid Tumors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Pfizer and BioNTech’s Innovative Vaccine Study: A Potential Game-Changer? - TipRanks

Oct 27, 2025
pulisher
Oct 24, 2025

Human Combinatorial Antibody Libraries Market to Surge USD 189.57 Million by 2034, Reports Towards Healthcare - GlobeNewswire Inc.

Oct 24, 2025
pulisher
Oct 24, 2025

Sector Gamma AS Grows Stake in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Oct 24, 2025
pulisher
Oct 14, 2025

BioNTech Clears Final Hurdle for $1.25 Billion CureVac Acquisition () - aktiencheck.de

Oct 14, 2025
pulisher
Oct 12, 2025

Aberdeen Group plc Grows Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Oct 12, 2025
pulisher
Oct 11, 2025

Mirae Asset Global Investments Co. Ltd. Purchases 533 Shares of BioNTech SE Sponsored ADR $BNTX - Defense World

Oct 11, 2025
pulisher
Oct 08, 2025

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead - The Globe and Mail

Oct 08, 2025
pulisher
Oct 08, 2025

Shell Asset Management Co. Buys 5,398 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

BioNTech SE Sponsored ADR $BNTX Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Slow Capital Inc. Sells 3,415 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

AstraZeneca Upgraded, Home Depot Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Oct 06, 2025
pulisher
Oct 02, 2025

Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? - The Globe and Mail

Oct 02, 2025
pulisher
Oct 01, 2025

Why BioNTech Stock Jumped by Nearly 4% on Wednesday - The Globe and Mail

Oct 01, 2025
pulisher
Sep 25, 2025

TB Alternative Assets Ltd. Trims Stock Holdings in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Sep 25, 2025
pulisher
Sep 23, 2025

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

JPMorgan Chase & Co. Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Sep 23, 2025
pulisher
Sep 22, 2025

Baader Bank Aktiengesellschaft Acquires 9,040 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

37,500 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Swedbank AB - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Rep. Val T. Hoyle Sells BioNTech SE Sponsored ADR (NASDAQ:BNTX) Shares - MarketBeat

Sep 21, 2025

Biontech Se Adr Azioni (BNTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.45
price down icon 0.83%
$93.26
price up icon 0.46%
biotechnology ONC
$309.19
price up icon 0.62%
$37.06
price up icon 0.41%
$193.06
price down icon 1.39%
Capitalizzazione:     |  Volume (24 ore):